Bristol Myers Squibb, 2seventy bio to discontinue enrollment in phase 3 KarMMa-9 study of Abecma in patients with newly diagnosed MM: Princeton, New Jersey Friday, September 27, 2 ...
USV introduces quinidine sulphate tablets for patients with rare irregular heartbeat conditions: Our Bureau, Mumbai Friday, September 27, 2024, 16:30 Hrs [IST] USV Pvt Ltd, a lead ...
WHO releases guidance to improve the design, conduct and oversight of clinical trials: Geneva Friday, September 27, 2024, 14:00 Hrs [IST] The World Health Organization (WHO) relea ...
Roche announces positive results from phase III study of Gazyva/Gazyvaro in people with lupus nephritis: Basel Friday, September 27, 2024, 12:00 Hrs [IST] Roche announced positive ...
Boehringer Ingelheim expands cancer research at its Vienna site: Ingelheim, Germany Friday, September 27, 2024, 13:00 Hrs [IST] Boehringer Ingelheim, one of the world's leading re ...
Stryker introduces 1788, next generation of advanced surgical camera in India, elevating surgical visualization across specialties: Our Bureau, Mumbai Friday, September 27, 2024, ...
Care.fi secures Rs. 8 crore impact debt funding to accelerate growth in Indian healthcare-focused fintech sector: Our Bureau, Mumbai Friday, September 27, 2024, 11:45 Hrs [IST] Ca ...
US FDA approves AstraZeneca’s Tagrisso for patients with unresectable, stage III EGFR-mutated lung cancer: Cambridge, UK Friday, September 27, 2024, 11:00 Hrs [IST] AstraZenecas ...
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies: Berlin, Germany Friday, September 27, 2024, 09:00 Hrs [IST] Bayer AG and Asklepios BioPhar ...
Pfizer voluntarily withdraws all lots of sickle cell disease treatment Oxbryta from worldwide markets: New York Friday, September 27, 2024, 10:00 Hrs [IST] Pfizer Inc. announced t ...